Dr. Frank Baciewicz, Jr. is a thoracic and cardiothoracic surgeon at the Karmanos Cancer Institute and part of the Multidisciplinary Team of the Thoracic Oncology Program. He treats patients diagnosed with lung cancer and esophageal cancer, and his special clinical interests include minimally invasive robotic lung surgery, thoracoabdominal aneurysm surgery, ascending aorta, mediastinal tumors, descending
As a clinician at the Karmanos Cancer Institute in Detroit Michigan, Dr. Dipesh Uprety is actively involved in patient care within the Department of Thoracic Oncology. A specialist in lung cancer, thymoma and thymic carcinomas, and malignant pleural mesothelioma, he is particularly interested in how these challenging forms of cancer respond to treatment, and how
Dr. Tarik Hadid is a medical oncologist and hematologist who specializes in head and neck cancers and thoracic cancers. As a member of the Karmanos Cancer Institute’s Thoracic Oncology Program’s Multidisciplinary Team, he collaborates with other specialists to treat esophageal cancer, malignant pleural mesothelioma, lung cancer, and thymoma and thymic malignancies. This approach brings comprehensive expertise
Dr. Hirva Mamdani is a thoracic medical oncologist who specializes in the diagnosis and treatment of patients with malignant pleural mesothelioma, esophageal cancer, lung cancer, and other thoracic malignancies. She is the head of the Thoracic Oncology Multidisciplinary Team at Karmanos Cancer Institute in Detroit and is the Director of Lung Cancer Screening there. She is
Dr. Scott J. Swanson is an accomplished general and thoracic surgeon at the Dana-Farber Cancer Institute and Brigham & Women’s Hospital in Boston. He is the Director of Brigham & Women’s Minimally Invasive Thoracic Surgery Program at Brigham and Women’s Hospital and serves as Chief Surgical Officer and Thoracic Oncology Disease Center Leader for the
Dr. Pasi A. Jänne is a leading researcher and clinician in medical oncology and lung cancer. He is the Co-Leader of the Lung Cancer Program at Dana-Farber Harvard Cancer and sees patients at the Dana-Farber Institute Lowe Center for Thoracic Oncology. Dr. Jänne was one of the co-discoverers of epidermal growth factor receptor (EGFR) mutations.
Two of America’s most highly respected mesothelioma professionals have been named to new positions at the prestigious International Mesothelioma Interest Group (iMig). Joseph Friedberg, MD, FACS, and Melissa Culligan, RN, BSN, MSc, PhD candidate will bring the expertise that they deploy at Temple Health, the Lewis Katz School of Medicine at Temple University, and Fox
Dr. Bruce E. Johnson is a world-renowned lung cancer physician-scientist. As leader of the Lung Cancer Program for the Dana-Farber/Harvard Cancer Center in Boston, he oversees research that integrates the facilities’ patient populations and science and applies what is discovered to the treatment of patients with lung cancer, malignant mesothelioma, and other thoracic malignancies. Under
Dr. Hassan A. Khalil is a thoracic surgeon at both Brigham and Women’s Hospital and Dana-Farber Cancer Institute. He specializes in minimally invasive surgical techniques in the treatment of thoracic and foregut diseases including malignant mesothelioma and lung cancer. He is a certified robotic console surgeon in the da Vinci Xi robotic platform and is also
Dr. David M. Jackman is a thoracic oncologist who is dedicated to improving outcomes for patients diagnosed with lung cancer, malignant pleural mesothelioma, and thymic tumors at the Dana-Farber Cancer Institute. As a physician member of the Lowe Center for Thoracic Oncology, he collaborates with experts across medical disciplines to coordinate and create a plan